Quantification of the severity of overt psychotic symptoms.
about
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersTrifluoperazine versus placebo for schizophreniaDroperidol for acute psychosisDroperidol for acute psychosis.Droperidol for psychosis-induced aggression or agitation.Symptomatology differentials between Negro and white schizophrenics.Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy.
P2860
Q24186601-C5C98FD5-D6AE-448F-A5EB-9A3BE2ACA365Q24201149-9F7DAE48-EF1D-4A1E-AC75-FA5466927E0FQ24247405-E4BA2756-AB0B-4AA9-997F-5381D0791C74Q34281951-BD421A21-7B04-44AA-82E6-27362766E770Q39038866-F4F691B9-0987-4EDF-8ABE-3B3F1A2E3F72Q47797253-8DA585B4-6351-4B3A-951D-E68063522A71Q52047236-A0D2E7C5-2334-4BF9-ADD5-D647919E5B7E
P2860
Quantification of the severity of overt psychotic symptoms.
description
1953 nî lūn-bûn
@nan
1953年の論文
@ja
1953年学术文章
@wuu
1953年学术文章
@zh
1953年学术文章
@zh-cn
1953年学术文章
@zh-hans
1953年学术文章
@zh-my
1953年学术文章
@zh-sg
1953年學術文章
@yue
1953年學術文章
@zh-hant
name
Quantification of the severity of overt psychotic symptoms.
@en
Quantification of the severity of overt psychotic symptoms.
@nl
type
label
Quantification of the severity of overt psychotic symptoms.
@en
Quantification of the severity of overt psychotic symptoms.
@nl
prefLabel
Quantification of the severity of overt psychotic symptoms.
@en
Quantification of the severity of overt psychotic symptoms.
@nl
P356
P1476
Quantification of the severity of overt psychotic symptoms.
@en
P2093
GOODRICH DW
P304
P356
10.1176/AJP.110.5.334
P407
P577
1953-11-01T00:00:00Z